Legislation Regarding Generic Drugs

In 1984, the Hatch-Waxman Drug Price Competition and
Patent Restoration Act was passed.  This was an
important development that changed forever the economics of the
pharmaceutical industry.  



NEJM has a nice, short, open-access href="http://content.nejm.org/cgi/content/full/357/20/1993">article
on the history and consequences of the Act.  



The author, Richard
G. Frank
, Ph.D., points out some interesting facts:



  • Today, generic drugs account for 63% of all U.S.
    prescriptions for drugs
  • Between 2007 and 2010, roughly 110 drugs will
    lose their patent protection
  • The first firm that files an Abbreviated New
    Drug Application is granted a 180-day period of exclusive marketing
    among generic products.
  • If a patent-infringement action is initiated by
    a brand-name manufacturer within 45 days of the noninfringement claim,
    the FDA cannot approve a generic product for 30 months or until the
    litigation is resolved.



Now, the average drug is covered by 10 separate patents.  As
you can imagine, this has resulted in an avalanche of litigation,
whenever a widely-used drug nears the end of its patent life.  



The whole thing is messy and difficult to understand, unless you follow
the field closely.  It is nice to have someone summarize the
situation in one article.



Tags

More like this

When generic drugs started to become popular, many people were skeptical.  Many people got switched from brand name to generic products, and complained that the generic did not work as well. These complaints often were treated with skepticism.  After all, generic drugs contain the same active…
This issue was brought up by my fellow blogger, Joseph at Corpus Callosum, following an article in yesterday's LA Times. For those not familiar with the concept or countries other than the US where laws may differ, generic drugs are those with the same active chemical as the originally-approved "…
This post is not interesting to specialists, but may be of some use to others.  I'm writing it mostly because the matter has been href="http://www.washingtonpost.com/wp-dyn/content/article/2006/06/12/AR2006061200722.html">reported in the mainstream press, and I think some clarification is in…
Rebecca Skloot, journalist, University of Memphis writing professor, and author of the upcoming book, The Immortal Life of Henrietta Lacks (pre-order here), just brought to my attention this commentary by Dr Pieter Cohen in the New England Journal of Medicine entitled, "American Roulette --…